Industry Insights

  1. Getting Executive Backing For A Digital QMS 8/26/2021

    This article offers guidance that will help you quantify and communicate the importance of quality, and how a digital QMS delivers considerable savings.

  2. TMT Labeling For Optimized Sample Preparation In Quantitative Proteomics 5/13/2025

    Leverage the power of Tandem Mass Tags (TMT) quantitative proteomics to gain deep insights into cellular dynamics, disease mechanisms, and drug targeting.

  3. Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C

    This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.

  4. Innovations In Peptide Manufacturing 1/23/2025

    The peptide manufacturing industry is evolving to meet the demands of efficiency, scalability, and sustainability. Learn how the latest innovations are addressing these challenges.

  5. Solid Tumors: The Next Frontier Of Cancer Immunotherapy 2/14/2024

    With the use of advanced in vitro models like Organ-Chips, researchers are gaining a better understanding of CAR T-cell therapy in the context of solid tumors.

  6. Establishing A Remote Audit Process As A CDMO 1/20/2021

    Compliance audits are not immune to the effects of the pandemic. We have been required to adapt quickly to the changing environment to maintain high service levels while protecting employee and client safety.

  7. Prioritize Solvent Recycling And Recovery To Realize Your Green Goals

    Building more sustainable practices across the pharmaceutical industry takes a collaborative and transparent effort. One leading CDMO is leveraging its solvent recovery efforts to yield major strides.

  8. Inclusion Of Health-Related Quality Of Life (HRQoL) And Other Patient-Reported Outcomes (PROs) In FDA Labels 6/12/2025

    With a growing emphasis on patient-centric drug development, new research examines how frequently patient-reported outcomes are actually making it onto United States Food and Drug Administration labels.

  9. Building An All-Star Biotech Team 6/8/2020

    Building your biotech team isn’t easy, but it’s central to your value. In fact, Roivant Sciences founder and CEO Vivek Ramaswamy believes people are the most important ingredient for launching a biopharma company. Here he shares more about why finesse, not formula, should drive your hiring decisions.

  10. Comment On Biopharmaceutical Classification System And Formulation Development 10/26/2012

    This is the first installment in a series of articles that will provide an overview of an area of potential interest to the readers of Pharmaceutical Online and Outsourced Pharma. By Mark Mitchnick, MD, and Robert W. Lee, PhD